ACE and vascular disorder: Furthermore, there were fewer multibranch vasculopathies, less use of aspirin, P2Y12 receptor inhibitors, β-blockers, and angiotensin converting enzyme inhibitor/angiotensin receptor blockers (ACEI/ARBs) after discharge, and more patients treated conservatively and fewer who underwent DES, with statistically significant differences (P < 0.05).